Hookipa Pharma Stock Filter Stocks by Fundamentals
| HOOK Stock | USD 0.76 0.05 6.17% |
Hookipa Pharma fundamentals help investors to digest information that contributes to Hookipa Pharma's financial success or failures. It also enables traders to predict the movement of Hookipa Stock. The fundamental analysis module provides a way to measure Hookipa Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Hookipa Pharma stock.
Hookipa | Shares Owned by Institutions |
Hookipa Pharma Institutional Holders
Institutional Holdings refers to the ownership stake in Hookipa Pharma that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Hookipa Pharma's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Hookipa Pharma's value.| Shares | Acadian Asset Management Llc | 2023-12-31 | 474.7 K | Blackrock Inc | 2023-12-31 | 294.3 K | Royal Bank Of Canada | 2023-12-31 | 220.3 K | Renaissance Technologies Corp | 2023-12-31 | 188.6 K | State Street Corporation | 2023-12-31 | 160.2 K | Boothbay Fund Management, Llc | 2023-12-31 | 117.7 K | Northern Trust Corp | 2023-12-31 | 111 K | Xtx Topco Ltd | 2023-12-31 | 105.8 K | Bridgeway Capital Management, Llc | 2023-12-31 | 87.5 K | Baker Bros Advisors Lp | 2023-12-31 | 8.1 M | Artal Group S A | 2023-12-31 | 5.7 M |
Hookipa Fundamentals
| Return On Equity | -0.85 | ||||
| Return On Asset | -0.32 | ||||
| Operating Margin | (2.45) % | ||||
| Current Valuation | (30.4 M) | ||||
| Shares Outstanding | 96.55 M | ||||
| Shares Owned By Insiders | 19.59 % | ||||
| Shares Owned By Institutions | 39.37 % | ||||
| Number Of Shares Shorted | 315.9 K | ||||
| Price To Earning | 12.06 X | ||||
| Price To Book | 0.87 X | ||||
| Price To Sales | 3.87 X | ||||
| Revenue | 20.13 M | ||||
| Gross Profit | (52.97 M) | ||||
| EBITDA | (81.38 M) | ||||
| Net Income | (81.58 M) | ||||
| Cash And Equivalents | 117.92 M | ||||
| Cash Per Share | 2.16 X | ||||
| Total Debt | 6.56 M | ||||
| Debt To Equity | 0.05 % | ||||
| Current Ratio | 5.48 X | ||||
| Book Value Per Share | 0.91 X | ||||
| Cash Flow From Operations | (57.52 M) | ||||
| Short Ratio | 0.65 X | ||||
| Earnings Per Share | (0.86) X | ||||
| Price To Earnings To Growth | (0.19) X | ||||
| Target Price | 4.7 | ||||
| Number Of Employees | 151 | ||||
| Beta | 1.02 | ||||
| Market Capitalization | 80.14 M | ||||
| Total Asset | 161.34 M | ||||
| Retained Earnings | (369.26 M) | ||||
| Working Capital | 105.13 M | ||||
| Current Asset | 26.61 M | ||||
| Current Liabilities | 25.01 M | ||||
| Net Asset | 161.34 M |
About Hookipa Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Hookipa Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hookipa Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hookipa Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Hookipa Pharma Piotroski F Score and Hookipa Pharma Altman Z Score analysis. For more information on how to buy Hookipa Stock please use our How to buy in Hookipa Stock guide.You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Complementary Tools for Hookipa Stock analysis
When running Hookipa Pharma's price analysis, check to measure Hookipa Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hookipa Pharma is operating at the current time. Most of Hookipa Pharma's value examination focuses on studying past and present price action to predict the probability of Hookipa Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hookipa Pharma's price. Additionally, you may evaluate how the addition of Hookipa Pharma to your portfolios can decrease your overall portfolio volatility.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |
Is Hookipa Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hookipa Pharma. If investors know Hookipa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hookipa Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.86) | Revenue Per Share 0.213 | Quarterly Revenue Growth (0.05) | Return On Assets (0.32) | Return On Equity (0.85) |
The market value of Hookipa Pharma is measured differently than its book value, which is the value of Hookipa that is recorded on the company's balance sheet. Investors also form their own opinion of Hookipa Pharma's value that differs from its market value or its book value, called intrinsic value, which is Hookipa Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hookipa Pharma's market value can be influenced by many factors that don't directly affect Hookipa Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hookipa Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Hookipa Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hookipa Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.